U.K. court backs Teva's 2015 Copaxone patent; Vertex hikes forecast on strong Kalydeco sales;

@FiercePharma: ICYMI: Pfizer to split operations three ways. Yesterday's story | Follow @FiercePharma

@CarlyHFierce: India's Cadila Pharma selects site for $150M plant in Russia. Article | Follow @CarlyHFierce

> A U.K. appeals court upheld Teva Pharmaceutical Industries' ($TEVA) May 2015 patent on its key multiple sclerosis drug Copaxone after a U.S. appeals court overturned the same patent last week. Report

> Vertex Pharmaceuticals' ($VRTX) new drug for cystic fibrosis patients, Kalydeco, handily beat analyst expectations with $99 million in quarterly sales, inspiring the company to raise its full-year forecast. Report

> Perrigo ($PRGO) shares plummeted after yesterday's announcement that it had agreed to buy the Irish drugmaker Elan ($ELN) for $8.6 billion in cash and stock, but some analysts raised their price targets. Report

> Dr. Reddy's Laboratories posted a 7.4% increase in quarterly profits, disappointing analysts, after a drop in European revenue offset increased U.S. sales. Report

Medical Device News

@FierceMedDev: Intuitive doubles stock buyback to quell investor angst. Article | Follow @FierceMedDev

@MarkHFierce: Haemonetics lost money in FY 2014 Q1 - Manufacturing reorg and M&A costs contributed. Yesterday's story | Follow @MarkHFierce

@DamianFierce: In case you missed it last night: GE Healthcare is recalling scanners after patient crushed to death in U.S. Report | Follow @DamianFierce

 @MichaelGFierce: NeuroSigma to begin PhIII epilepsy device trial. ICYMI yesterday | Follow @MichaelGFierce

> Roche, Thermo unite for sepsis diagnostics. Article

> Foundation Medicine pursues $86.3M IPO. Story

> FDA's first-time PMAs down drastically so far in 2013. Item

Biotech News

@FierceBiotech: PR: Adocia, Eli Lilly end collaboration; Adocia reacquires exclusive development rights to insulin analog. Release | Follow @FierceBiotech

@RyanMFierce: Foundation Medicine seeks $86.3M IPO amid chase for reimbursement. Item | Follow @RyanMFierce

@EmilyMFierce: Novavax joins H7N9 vaccine race, reports positive preclinical data. Article | Follow @EmilyMFierce

> Sanofi, NEA team up in $18M round for rare disease outfit Edimer. Story

> Celgene inks $11M inflammation deal with Array BioPharma. News

> Synta Pharma rebounds on early results from drug study for breast cancer. Article

Biotech Research News

@EmilyMFierce: UCLA team IDs anti-amyloid compounds to treat Alzheimer's, other brain diseases. Story | Follow @EmilyMFierce

> Novavax joins H7N9 vaccine race, reports positive preclinical data. News

> Antibody effective at fighting norovirus in chimps. Story

> Novavax joins H7N9 vaccine race, reports positive preclinical data. Article

> Antibody effective at fighting norovirus in chimps. More

Pharma Manufacturing News

@EricPFierce: Lawmakers want assurances Smithfield sale to China's Shuanghui won't leave US drugmakers short of heparin. Report | Follow @EricPFierce

> Cadila Pharma selects site for $150M Russian plant. News

> Alexion adding 50 jobs in Ireland to grow global supply chain. Item

> Pfizer says investments in Ireland position plants for growth. More

> New Russian company to build $85M plant. Story

> Bristol-Myers turns to Samsung for cancer drug. Article

And Finally... Another reason to floss: Bacteria linked to gum disease moved to the brains of Alzheimer's patients, scientists said, suggesting dental hygiene may play a role in the disease. Report

Suggested Articles

Merck’s Keytruda went up against chemo in a head-to-head colorectal cancer battle—and won.

While the FDA gave an emergency green light to chloroquine's use against coronavirus, European regulators are restricting the drug to clinical trials.

Biocon has finally satisfied the FDA that its insulin production plant in Malaysia is ready for prime time.